Evaluation of a shared decision-making intervention for pediatric patients with asthma in the emergency department.
Implementation
Information technology
Innovation
Pediatric asthma
Shared decision making
Journal
Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360
Informations de publication
Date de publication:
2020
2020
Historique:
received:
01
11
2019
accepted:
09
12
2019
entrez:
5
9
2020
pubmed:
5
9
2020
medline:
5
9
2020
Statut:
epublish
Résumé
Asthma is a difficult-to-manage chronic disease marked with associated outcome disparities including an increase rate of emergency department (ED) visits for uncontrolled asthma among patients who are most at-risk. Shared decision making (SDM) is a process by which the patient and provider jointly make a healthcare choice. SDM improves patient outcomes; however, implementation barriers of time constraints and staff availability are limitations. The use of health IT solutions may increase the adoption of SDM, but best practices for implementation are not well understood. The Consolidated Framework for Implementation Research (CFIR) is a flexible comprehensive model used to identify barriers and facilitators influencing implementation. The goal of this study is to implement an innovative web-based pediatric SDM tool in the real-world setting of two large healthcare system EDs through the following aims: (1) convene a patient, research, and ED stakeholder advisory board to oversee review of protocol and study materials prior to implementation, (2) implement the SDM intervention where providers and staff will be trained to incorporate use of this SDM intervention, (3) conduct on-going evaluation of barriers, facilitators, and implementation outcomes to tailor implementation in the EDs, (4) evaluate patient-centered outcomes of primary care utilization and changes in ED visits and hospitalizations before and after the SDM intervention, and (5) understand and document best practices for ED implementation. The CFIR model will guide the implementation evaluation. Researchers will administer surveys to the clinical team and patients at baseline, 3, 6, and 12 months to inform implementation design, determine barriers and facilitators, and resource-needs to allow for real-time process adjustments within the EDs. Focus group or key-informant interviews and analysis will provide additional feedback to the stakeholder team to iterate the implementation process. Researchers will track patient-centered outcomes including increased primary care, ED, and inpatient utilization over the duration of the study. To advance asthma care and the field of implementation science, further research is needed to assess best practices for incorporating SDM into high-need healthcare settings such as the ED. This knowledge will facilitate improved outcomes and appropriate policy changes towards further use of SDM interventions in local and national acute care settings.
Sections du résumé
BACKGROUND
BACKGROUND
Asthma is a difficult-to-manage chronic disease marked with associated outcome disparities including an increase rate of emergency department (ED) visits for uncontrolled asthma among patients who are most at-risk. Shared decision making (SDM) is a process by which the patient and provider jointly make a healthcare choice. SDM improves patient outcomes; however, implementation barriers of time constraints and staff availability are limitations. The use of health IT solutions may increase the adoption of SDM, but best practices for implementation are not well understood. The Consolidated Framework for Implementation Research (CFIR) is a flexible comprehensive model used to identify barriers and facilitators influencing implementation. The goal of this study is to implement an innovative web-based pediatric SDM tool in the real-world setting of two large healthcare system EDs through the following aims: (1) convene a patient, research, and ED stakeholder advisory board to oversee review of protocol and study materials prior to implementation, (2) implement the SDM intervention where providers and staff will be trained to incorporate use of this SDM intervention, (3) conduct on-going evaluation of barriers, facilitators, and implementation outcomes to tailor implementation in the EDs, (4) evaluate patient-centered outcomes of primary care utilization and changes in ED visits and hospitalizations before and after the SDM intervention, and (5) understand and document best practices for ED implementation.
METHODS
METHODS
The CFIR model will guide the implementation evaluation. Researchers will administer surveys to the clinical team and patients at baseline, 3, 6, and 12 months to inform implementation design, determine barriers and facilitators, and resource-needs to allow for real-time process adjustments within the EDs. Focus group or key-informant interviews and analysis will provide additional feedback to the stakeholder team to iterate the implementation process. Researchers will track patient-centered outcomes including increased primary care, ED, and inpatient utilization over the duration of the study.
DISCUSSION
CONCLUSIONS
To advance asthma care and the field of implementation science, further research is needed to assess best practices for incorporating SDM into high-need healthcare settings such as the ED. This knowledge will facilitate improved outcomes and appropriate policy changes towards further use of SDM interventions in local and national acute care settings.
Identifiants
pubmed: 32885182
doi: 10.1186/s43058-020-00010-y
pii: 10
pmc: PMC7427946
doi:
Types de publication
Journal Article
Langues
eng
Pagination
22Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
J Sch Health. 2006 Jan;76(1):18-24
pubmed: 16457681
BMC Pulm Med. 2017 Jan 11;17(1):13
pubmed: 28077097
Patient Educ Couns. 2010 Jul;80(1):94-9
pubmed: 19879711
Implement Sci. 2014 Oct 29;9:158
pubmed: 25359128
PLoS One. 2015 Aug 19;10(8):e0136184
pubmed: 26288276
Trials. 2014 Jul 08;15:275
pubmed: 25004983
J Asthma. 2017 May;54(4):392-402
pubmed: 27813670
Acad Pediatr. 2015 Mar-Apr;15(2):225-30
pubmed: 25596899
Implement Sci. 2013 May 10;8:51
pubmed: 23663819
Acad Emerg Med. 2016 Dec;23(12):1313-1319
pubmed: 27396583
JMIR Mhealth Uhealth. 2018 Mar 22;6(3):e68
pubmed: 29567637
J Asthma. 2019 Oct;56(10):1087-1098
pubmed: 30252544
Vital Health Stat 3. 2012 Nov;(35):1-58
pubmed: 24252609
Implement Sci. 2016 May 17;11:72
pubmed: 27189233
JMIR Serious Games. 2019 Jun 1;7(2):e12431
pubmed: 31199324
Acad Emerg Med. 2015 Jul;22(7):856-64
pubmed: 26112797
J Emerg Nurs. 2015 Jan;41(1):13-8
pubmed: 25219951
J Asthma. 2018 Jun;55(6):675-683
pubmed: 28800266
J Asthma. 2014 May;51(4):380-90
pubmed: 24350877
NCHS Data Brief. 2012 May;(94):1-8
pubmed: 22617340
Chest. 1993 Oct;104(4):1144-8
pubmed: 8404182
J Sch Health. 2011 Oct;81(10):606-13
pubmed: 21923872
J Pediatr. 2005 May;146(5):591-7
pubmed: 15870660
Health Serv Res. 2017 Apr;52(2):599-615
pubmed: 27206519
J Pediatr. 2012 Aug;161(2):184-5
pubmed: 22608910
Am J Respir Crit Care Med. 2009 Nov 1;180(9):817-22
pubmed: 19644048
J Asthma. 2021 Apr;58(4):554-563
pubmed: 31868043
Fam Pract. 2016 Aug;33(4):426-31
pubmed: 27297465
BMJ Open. 2016 Aug 26;6(8):e010809
pubmed: 27566627
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Health Serv Res. 2018 Dec;53(6):4178-4203
pubmed: 30260471
Am J Respir Crit Care Med. 2010 Mar 15;181(6):566-77
pubmed: 20019345
Implement Sci. 2016 Dec 1;11(1):158
pubmed: 27906041
PLoS One. 2015 Apr 07;10(4):e0123182
pubmed: 25849962
PLoS One. 2017 Mar 30;12(3):e0173904
pubmed: 28358864
Implement Sci. 2017 Jan 5;12(1):2
pubmed: 28057049
J Allergy Clin Immunol. 2000 Jan;105(1 Pt 1):9-19
pubmed: 10629447
J Allergy Clin Immunol. 2016 Dec;138(6):1503-1510
pubmed: 27931532
Implement Sci. 2018 Mar 27;13(1):52
pubmed: 29587804
Patient Educ Couns. 2013 Oct;93(1):102-7
pubmed: 23768763
JMIR Mhealth Uhealth. 2017 Sep 28;5(9):e144
pubmed: 28958987
Pediatrics. 2016 Jan;137(1):
pubmed: 26712860
JAMA Intern Med. 2017 Jul 1;177(7):967-974
pubmed: 28505217